Literature DB >> 19122

Increased exercise tolerance with nitrates in beta-blockaded patients with angina.

R H Baxter, I M Lennox.   

Abstract

In 14 beta-blockaded anginal subjects, 10 of whom had poor left ventricular function, sublingual isosorbide dinitrate significantly increased maximal exercise capacity on a standardized multistage treadmill test. This was associated with changes in heart rate and blood pressure suggestive of a fall in left ventricular work. The effect of isosorbide lasts for at least two hours and when taken before exercise may be a useful addition to beta-blockade in patients with angina.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 19122      PMCID: PMC1631445          DOI: 10.1136/bmj.2.6086.550

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  USE OF PROPRANOLOL IN ANGINA PECTORIS.

Authors:  P M GILLAM; B N PRICHARD
Journal:  Br Med J       Date:  1965-08-07

2.  Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements.

Authors:  G Jackson; L Atkinson; S Oram
Journal:  Br Med J       Date:  1975-09-13

3.  Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease.

Authors:  R A Bruce; F Kusumi; D Hosmer
Journal:  Am Heart J       Date:  1973-04       Impact factor: 4.749

4.  Hemodynamic effects of nitroglycerin, propranolol, and their combination in coronary heart disease.

Authors:  L Wiener; E M Dwyer; J W Cox
Journal:  Circulation       Date:  1969-05       Impact factor: 29.690

5.  Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease.

Authors:  H Kasparian; L Wiener; P R Duca; R S Gottlieb; A N Brest
Journal:  Am Heart J       Date:  1975-07       Impact factor: 4.749

6.  Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle.

Authors:  L C Becker; N J Fortuin; B Pitt
Journal:  Circ Res       Date:  1971-02       Impact factor: 17.367

7.  The effect of propranolol in the long-term treatment of angina pectoris.

Authors:  H J Zeft; S Patterson; E S Orgain
Journal:  Arch Intern Med       Date:  1969-11

8.  Hemodynamic effects of isosorbide dinitrate vs nitroglycerin in patients with unstable angina.

Authors:  W H Willis; R O Russell; J A Mantle; R A Ratshin; C E Rackley
Journal:  Chest       Date:  1976-01       Impact factor: 9.410

9.  Improvement in left ventricular wall motion following nitroglycerin.

Authors:  J H McAnulty; M T Hattenhauer; J Rösch; F E Kloster; S H Rahimtoola
Journal:  Circulation       Date:  1975-01       Impact factor: 29.690

10.  DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS.

Authors:  P KEELAN
Journal:  Br Med J       Date:  1965-04-03
View more
  6 in total

1.  Mononitrates in combination with beta-blocker therapy in the treatment of severe angina pectoris.

Authors:  J H Svendsen; O Amtorp
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 2.  Combination of nitrates with other antianginal drugs.

Authors:  K E Andersson; P Hoglund
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.

Authors:  A Uusitalo
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Haemodynamic and clinical effects of isosorbide-dinitrate in patients with severe effort angina on beta-blocking treatment.

Authors:  G Jensen; F Trautner; S Rasmussen; B Hesse
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.

Authors:  M A James; P R Walker; M Papouchado; P R Wilkinson
Journal:  Br Heart J       Date:  1985-06

6.  Does the sympathetic nervous system influence sinus arrhythmia in man? Evidence from combined autonomic blockade.

Authors:  R Coker; A Koziell; C Oliver; S E Smith
Journal:  J Physiol       Date:  1984-11       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.